Image

Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer

Investigating Treatment Options for Non-resectable Pancreatic Cancer

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates non-resectable pancreatic cancer. The purpose of this study is to compare different chemotherapy treatments for patients who cannot undergo full-dose combination chemotherapy.

The study evaluates the effectiveness and safety of these treatments. It looks at how well the treatments work and how they affect the patients' quality of life.

  • Who can participate: Adults aged 18 and older with non-resectable pancreatic cancer can participate. They must be unable to have full-dose combination chemotherapy but eligible for full-dose gemcitabine or reduced-dose combination chemotherapy. Participants should have adequate blood and organ function.
  • Study details: Participants will be assigned to receive either full-dose or reduced-dose chemotherapy.
Print
Study details
    Pancreas Cancer
    Non-Resectable Pancreas Carcinoma

NCT05841420

Morten Ladekarl

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.